Beware: Private Equity Firms Facing Heightened False Claims Act and Antitrust Risks


It is more important than ever for private equity firms to be proactive with efforts to mitigate emerging False Claims Act (FCA) and antitrust risks. As the government tries to protect the Medicare trust fund from insolvency, and whistleblowers seek financial windfalls from investors with “deeper pockets,” private equity firms need new strategies to protect their capital as they face increased exposure to potentially catastrophic FCA and antitrust liability through targeted investigations and lawsuits. Please join us as we discuss recent enforcement trends and how best to manage this new level of risk.

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.